Senate Files

Bills

S. 113 118th Congress

Prescription Pricing for the People Act of 2023

Latest action, Mar 1, 2023: Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

21 cosponsors

Sponsored by Chuck Grassley (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
10 D · 10 R · 1 I
  • Democrat
  • Republican
  • Independent
21 senators cosponsoring

Referred to: Senate: Judiciary Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

41 clientsQ1 2023Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
8 reports
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
8 reports
AMERICAN MEDICAL ASSOCIATION
8 reports
AMGEN INC
8 reports
AMGEN USA INC.
MARSHALL & POPP, LLC
8 reports
BIOTECHNOLOGY INNOVATION ORGANIZATION
8 reports
CENCORA, INC.
TCH GROUP, LLC
8 reports
CROHN'S & COLITIS FOUNDATION
8 reports
FRESENIUS KABI USA LLC
WEST FRONT STRATEGIES LLC
8 reports
GENENTECH, INC.
MARSHALL & POPP, LLC
8 reports
GSK (FKA GLAXOSMITHKLINE INC.)
8 reports
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
8 reports
NATIONAL MULTIPLE SCLEROSIS SOCIETY
8 reports
PFIZER, INC.
MARSHALL & POPP, LLC
8 reports
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
E3 STRATEGIC CONSULTING GROUP
8 reports
All 25 of 53 clients
ClientLobbying firmReportsReports totalingFromToSenate
AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)8$24.8MQ1 2023Q3 2024yes
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)8$30KQ1 2023Q3 2024yes
AMERICAN MEDICAL ASSOCIATION8$44.9MQ1 2023Q3 2024yes
AMGEN INC8$22.9MQ1 2023Q3 2024yes
AMGEN USA INC.MARSHALL & POPP, LLC8$0Q1 2023Q3 2024yes
BIOTECHNOLOGY INNOVATION ORGANIZATION8$15.7MQ1 2023Q3 2024yes
CENCORA, INC.TCH GROUP, LLC8$0Q1 2023Q3 2024yes
CROHN'S & COLITIS FOUNDATION8$390KQ1 2023Q3 2024yes
FRESENIUS KABI USA LLCWEST FRONT STRATEGIES LLC8$0Q1 2023Q3 2024yes
GENENTECH, INC.MARSHALL & POPP, LLC8$0Q1 2023Q3 2024yes
GSK (FKA GLAXOSMITHKLINE INC.)8$9.9MQ1 2023Q3 2024yes
NATIONAL COMMUNITY PHARMACISTS ASSOCIATION8$2.9MQ1 2023Q3 2024yes
NATIONAL MULTIPLE SCLEROSIS SOCIETY8$551KQ1 2023Q3 2024yes
PFIZER, INC.MARSHALL & POPP, LLC8$0Q1 2023Q3 2024yes
PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATIONE3 STRATEGIC CONSULTING GROUP8$200KQ1 2023Q3 2024yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA8$58.1MQ1 2023Q3 2024yes
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAMARSHALL & POPP, LLC8$0Q1 2023Q3 2024yes
SANOFI U.S. SERVICES, INC.MARSHALL & POPP, LLC8$480KQ1 2023Q3 2024yes
TEVA PHARMACEUTICALS USA INC8$4.4MQ1 2023Q3 2024yes
THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)8$18.7MQ1 2023Q3 2024yes
NOVARTIS7$10.7MQ1 2023Q3 2024yes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION7$28.0MQ1 2023Q3 2024yes
AARP5$22.4MQ1 2023Q2 2024yes
CIGNA CORPORATIONINVARIANT LLC5$450KQ1 2023Q1 2024yes
ELEVANCE HEALTH, INC.5$8.8MQ1 2023Q3 2024yes